Yes Indeed. I think that a lot of investors are underestimating $OPK . Rayaldee could be wiorth 5 BILLION if trials come out over 90% recuperating patients. And the reason behind it is PREVENTION ! $OPK is better off selling to Pfizer for 20 Billion . Frost made a deal for over 7.5 billion . I believe $OPK is worth 20 billion market cap by end of 2021 taking into consideration Somatrogon and Rayaldee success